Pfizer targets at least 2 billion COVID-19 vaccine doses this year, sees $15 billion in 2021 from the shots

Pfizer Inc said on Tuesday it expects to generate $15 billion, or about a quarter of its total revenue this year, from sales of its COVID-19 vaccine co-developed with German partner BioNTech SE.